SEGMENTED INFORMATION

12 Months Ended

Sep. 30, 2012

Segment Reporting [Abstract]

NOTE 14. SEGMENTED INFORMATION

The Company operates in one business segment, namely human therapeutics. Results of operations are reported on a consolidated basis for segment reporting purposes. Consolidated disclosures about revenue streams and long-lived assets by geographic area are seen below.

Revenues

The Company derived revenues from royalties and from consulting services for the year ended September 30, 2012 and 2011.

	Years ended September 30,
Revenue Stream	2012		2011
Third Party Royalties (Mexico)		166,803		158,166
Consulting Fees (North America)		0		25,337
Gross Operating Revenue		166,803		183,503
Other non-operating revenue:
Forgo Salary		117,300
Gain from disposal of fixed assets		67,077
Legal Settlement		59,949
Interest Income		683
Total Revenues and Non-Operating Revenues	$	411,812	$	183,503
Long Lived Assets
	Years ended September 30,
Long Lived Assets		2012		2011
North America	$	0	$	9,790
Asia		-		-
Total Long Lived Assets	$	0	$	9,790